Omega promo web banner
Omega promo Mobile banner

Top Pharma Companies in India by Market Cap

Sensex 81118.60
573.38 (-0.70%)
×
×
Filter
Top Pharma Companies in India as on Jun-2025 |
 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks
Filter
Company Name
Market cap
(Rs. Cr.)
CMP
(Change %)
Latest
P/E
Latest
P/BV
5Y Sales
Gr.(%)
5Y Profit
Gr.(%)
DeciZen
More Info
1
Aarti Drugs Ltd.
4,235
(Small Cap)
464
(-2.06%)
25.71
3.16
10.13
15.12
Q V PT
2
Aarti Pharmalabs Ltd.
8,026
(Small Cap)
885.55
(-3.59%)
32.35
4.52
0.00
0.00
Q V+ PT
3
Abbott India Ltd.
67,031
(Mid Cap)
31,545.15
(0.22%)
47.29
15.8
9.72
21.88
Q V+ PT
4
Acutaas Chemicals Ltd.
9,040
(Small Cap)
1,104.15
(0.03%)
56.64
6.89
23.89
15.28
Q V PT
5
Advanced Enzyme Technologies Ltd.
3,587
(Small Cap)
320.60
(-1.38%)
35.51
5.78
10.48
27.93
Q V PT
6
Ajanta Pharma Ltd.
32,922
(Mid Cap)
2,635.65
(-3.41%)
37.03
8.99
15.41
16.56
Q V PT
7
Akums Drugs & Pharmaceuticals Ltd.
8,990
(Small Cap)
571.20
(0.30%)
55.68
3.89
16.15
2.40
Q V+ PT
8
Alembic Pharmaceuticals Ltd.
19,643
(Small Cap)
999.30
(0.86%)
33.38
3.75
9.62
0.22
Q V PT
9
Alivus Life Sciences Ltd.
12,424
(Small Cap)
1,013.10
(-1.62%)
N/A
N/A
20.83
15.64
Q V+ PT
10
Alkem Laboratories Ltd.
57,966
(Mid Cap)
4,848.10
(0.07%)
27.72
4.7
11.27
17.59
Q V+ PT
11
Apollo Hospitals Enterprise Ltd.
1,00,546
(Large Cap)
6,992.80
(-0.03%)
77.58
11.51
-2.69
26.09
Q V+ PT
12
Artemis Medicare Services Ltd.
3,605
(Small Cap)
259.50
(-0.31%)
43.33
4.68
9.11
0.00
Q V PT
13
Aster DM Healthcare Ltd.
29,525
(Small Cap)
569.85
(0.96%)
5.44
6.84
-14.22
-18.00
Q V+ PT
14
Astrazeneca Pharma India Ltd.
26,312
(Small Cap)
10,524.65
(3.40%)
219.86
33.03
12.21
22.75
Q V+ PT
15
Aurobindo Pharma Ltd.
66,830
(Mid Cap)
1,150.65
(-0.38%)
38.4
3.27
-2.78
4.44
Q V PT
16
Biocon Ltd.
42,675
(Mid Cap)
355.45
(0.87%)
69.44
3.67
-3.80
31.80
Q V PT
17
Bliss GVS Pharma Ltd.
1,575
(Small Cap)
149.35
(0.50%)
22.72
1.48
7.25
4.05
Q V PT
18
Blue Jet Healthcare Ltd.
16,554
(Small Cap)
954.30
(-0.98%)
54.77
14.75
0.00
0.00
Q V+ PT
19
Caplin Point Laboratories Ltd.
16,270
(Small Cap)
2,140.40
(1.24%)
29.96
5.64
21.17
21.55
Q V PT
20
Cipla Ltd.
1,21,592
(Large Cap)
1,505.40
(0.22%)
23.01
3.89
9.51
24.56
Q V+ PT
21
Cohance Lifesciences Ltd.
38,404
(Small Cap)
1,003.85
(-0.18%)
143.63
22.51
22.71
0.00
Q V+ PT
22
Concord Biotech Ltd.
22,080
(Small Cap)
2,110.55
(2.44%)
58
11.89
0.00
0.00
Q V PT
23
Dishman Carbogen Amcis Ltd.
4,381
(Small Cap)
279.45
(-0.55%)
N/A
0.76
4.91
-191.53
Q V PT
24
Divis Laboratories Ltd.
1,77,076
(Large Cap)
6,670.30
(-0.78%)
81.45
11.92
9.66
3.51
Q V+ PT
25
Dr. Lal Pathlabs Ltd.
24,747
(Small Cap)
2,954
(-0.52%)
50.03
11.97
13.05
17.98
Q V PT
26
Dr. Reddys Laboratories Ltd.
1,13,615
(Large Cap)
1,361.45
(-0.12%)
20.12
3.39
12.64
24.49
Q V PT
27
Emcure Pharmaceuticals Ltd.
25,824
(Small Cap)
1,362.70
(-1.12%)
82.34
8.63
7.35
-11.52
Q V PT
28
Eris Lifesciences Ltd.
24,438
(Small Cap)
1,794.30
(0.23%)
69.3
8.54
15.39
6.32
Q V PT
29
FDC Ltd.
7,752
(Small Cap)
476.15
(3.44%)
27.39
3.28
12.24
13.06
Q V PT
30
Fortis Healthcare Ltd.
56,920
(Mid Cap)
753.95
(-0.68%)
898.4
6.32
12.47
10.01
Q V+ PT
Prev 1

Want to pick best stocks Undervalued Pharma Stocks for High returns?

Check Now!
Screens:
AlphaCases All-Weather Stocks Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks
×
×

Pharma - Today's Top Gainers

Company Name CMP Price Change(%)
Narayana Hrudayalay
1,913.255.09%
Tarsons Products
390.404.48%
RPG Life Sciences
2,339.504.07%
Thyrocare Tech.
1,022.153.83%
Strides Pharma Scien
883.403.53%
View More

Pharma - Today's Top Losers

Company Name CMP Price Change(%)
Suven Life Sciences
235.65-9.64%
Innova Captab
909.10-3.80%
Guj. Themis Biosyn
333.75-3.69%
Aarti Pharmalabs
885.55-3.59%
Themis Medicare
139.70-3.42%
View More

News about Top Pharma Companies in India

Bliss GVS Pharma informs about outcome of postal ballot

In continuation of earlier intimation dated May 12, 2025, informing regarding the Postal Ballot Notice for seeking approval of the Members of the Company by way of Special Resolutions in respect of the agenda items as stated in the said Notice dated May 12, 2025; Bliss GVS Pharma has informed that Vijay Yadav, Partner of AVS & Associates, Practicing Company Secretary who was appointed as the Scrutinizer for the aforesaid Postal Ballot and e-voting process has submitted his report to the Company on Wednesday, June 11, 2025. Further, pursuant to Section 108, 110 of the Companies Act, 2013, and the Rules framed thereunder read with Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, they are enclosing the Voting Results along with the Scrutinizers Report for reference. The same is also uploaded on the website of the Company www.blissgvs.com

The above information is a part of company’s filings submitted to BSE.

12 Jun, 2025

Bliss GVS Pharma informs about disclosure

Bliss GVS Pharma has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gagan Harsh Sharma & PACs.

The above information is a part of company’s filings submitted to BSE.
12 Jun, 2025

Artemis Medicare Services informs about outcome of board meeting

Artemis Medicare Services has informed that the Board of Directors of the Company, at its meeting held today, June 11, 2025, approved the proposal to enter into a binding Memorandum of Understanding (‘MOU’) with Dr. Vidya Sagar Kaushalya Devi Memorial Health Centre (‘the Society’). As per the terms of MOU, upon completion of certain conditions prescribed, the Company and the Society will execute a Medical Services Agreement (‘MSA’) for granting the exclusive rights to the Company to operate, manage, and provide medical services at the Society’s hospital namely Vidyasagar Institute of Mental Health and Neuro & Allied Sciences (VIMHANS) located in Nehru Nagar, New Delhi. The Company is expected to incur an investment of ~ Rs. 550 - 600 crore for the project in next 2-3 years, to be funded by a combination of internal accruals and debt financing. The details as required under the SEBI Listing Regulations, are provided in 'Annexure A'. Further details of the aforesaid transaction will be disclosed on the execution of said MSA. The meeting of the Board of Directors commenced at 2:00 PM and concluded at 3:35 PM.

The above information is a part of company’s filings submitted to BSE.

11 Jun, 2025

Alkem Laboratories informs about analyst meet

Provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alkem Laboratories has informed about the details of Analyst / Institutional Investor meeting to be conducted as on 17th June, 2025.

The above information is a part of company’s filings submitted to BSE.

11 Jun, 2025

Alivus Life Sciences informs about analyst meet

Alivus Life Sciences has informed that pursuant to Regulation 30 and Para A of Part A of Schedule III of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, details of the meetings with Investor/Analyst which will be held on June 12, 2025 and attended by the representatives of the Company is enclosed.

The above information is a part of company’s filings submitted to BSE.

09 Jun, 2025

Bliss GVS Pharma informs about allotment of shares

Bliss GVS Pharma has informed that, the ESOP Allotment Committee of the Company at its meeting held today June 06, 2025, has approved the allotment of 75,250 equity shares of the face value of Re. 1/- each to the eligible employee who has exercised its stock options under Bliss GVS Pharma Limited–Employee Stock Option Plan 2019 (‘Bliss GVS ESOP-2019’). Consequent to the aforesaid allotment, issued, subscribed & paid-up share capital of the Company has increased from ‘10,53,70,273 equity shares of Re. 1/- each aggregating Rs. 10,53,70,273/- ‘ to ‘10,54,45,522 equity shares of Re. 1/- each aggregating Rs. 10,54,45,522 /-‘. In terms of Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 the details of shares allotted as above are given in ‘Annexure-I’ to this intimation.

The above information is a part of company’s filings submitted to BSE.
06 Jun, 2025

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2025.

Rank Company Market Capitalization 2025 (INR  crores)
1 Aarti Drugs Ltd. 4,235 Crore
2 Aarti Pharmalabs Ltd. 8,026 Crore
3 Abbott India Ltd. 67,031 Crore
4 Acutaas Chemicals Ltd. 9,040 Crore
5 Advanced Enzyme Technologies Ltd. 3,587 Crore
6 Ajanta Pharma Ltd. 32,922 Crore
7 Akums Drugs & Pharmaceuticals Ltd. 8,990 Crore
8 Alembic Pharmaceuticals Ltd. 19,643 Crore
9 Alivus Life Sciences Ltd. 12,424 Crore
10 Alkem Laboratories Ltd. 57,966 Crore
Find best pharma stocks to buy now
Do you know?
Asking 3 Right Questions minimizes the
RISK of Stock Investing
To Know
Right Stock | Right Price | Right Allocation
Find best stocks to buy now

Top Pharma Companies FAQs Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA ROE
Abbott India Ltd. (M) Very Good 31,545 67,031 47.39 15.83 33.20 34.87
Natco Pharma Ltd. (S) Very Good 912.5 16,345 8.67 2.15 5.66 25.73
Torrent Pharmaceuticals Ltd. (L) Very Good 3,251 1,10,024 57.57 14.49 30.04 24.28
Ajanta Pharma Ltd. (M) Very Good 2,636 32,922 35.77 8.69 24.19 23.04
Dr. Reddys Laboratories Ltd. (L) Very Good 1,361 1,13,615 20.09 3.39 11.96 21.33

Based on the past year's gain, the best performing stocks are:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) Yearly gain (%)
Laurus Labs Ltd. (S) Very Good 667.0 35,992 51.72
Divis Laboratories Ltd. (L) Very Good 6,670 1,77,076 45.23
Glenmark Pharmaceuticals Ltd. (M) Somewhat Good 1,670 47,119 36.27
Lupin Ltd. (L) Somewhat Good 2,000 91,355 24.61
Abbott India Ltd. (M) Very Good 31,545 67,031 14.24
View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Sales Growth (%)
Mankind Pharma Ltd. (L) Very Good 2,382 98,310 52.17 6.71 34.44 19.33
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,732 27,045 41.45 8.01 25.61 17.05
Ajanta Pharma Ltd. (M) Very Good 2,636 32,922 35.77 8.69 24.19 15.41
Gland Pharma Ltd. (S) Very Good 1,689 27,832 25.54 2.85 15.32 15.31
Laurus Labs Ltd. (S) Very Good 667.0 35,992 100.5 8.09 34.10 14.42

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name Is it a Right Stock ? CMP Market Cap(Cr.) P/E P/BV EV/EBITDA 5Y Profit Growth (%)
Lupin Ltd. (L) Somewhat Good 2,000 91,355 27.84 5.31 17.03 36.90
Biocon Ltd. (M) Somewhat Good 355.4 42,675 70.04 3.70 108.3 31.80
Mankind Pharma Ltd. (L) Very Good 2,382 98,310 52.17 6.71 34.44 29.77
JB Chemicals & Pharmaceuticals Ltd. (S) Very Good 1,732 27,045 41.45 8.01 25.61 26.08
Granules India Ltd. (S) Very Good 509.4 12,356 38.69 3.63 21.46 24.68
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now
SEBI Registered: Investment Adviser - INA000013323 RIA Details
Request a Call back
Refer and Earn
Partner with Us
WhatsApp +91 9860359463
besafe@moneyworks4me.com
Warning: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer: Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provides any assurance of returns to investors.
Compliance Officer:
Name: Shrikant Jagtap
Email: shrikant.jagtap@moneyworks4me.com
Mobile No: +91 97638 00745
Grievance Officer:
Name: Mukta Vaze
Email: mukta.vaze@moneyworks4me.com
Mobile No:+91 98609 19463
Principal Officer:
Name: Atharva Bhide
Email: atharva.bhide@moneyworks4me.com
Mobile No:+91 91758 99463
SEBI regional/local office address-
Plot No. C 4-A , G Block, Near Bank of India, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra 400051
linkedin facebook twitter youtube insta telegram
Address:
The Alchemists Ark Pvt. Ltd., B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Complaints: Complaint status | Cancellation and Refund Policy | PML Act | Grievance Redressal Process | ODR | Investor charter | Terms & Conditions | Disclaimer | Disclosure
Data provided by Accord Fintech Pvt. Ltd.
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...